Ling Huw
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, PI3K/AKT/mTOR signaling in cancer, Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies, Epigenetics and DNA Methylation
Most-Cited Works
- → Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL(2007)602 cited
- → A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types(2018)210 cited
- → Phosphoinositide 3-Kinase (PI3K) Pathway Alterations Are Associated with Histologic Subtypes and Are Predictive of Sensitivity to PI3K Inhibitors in Lung Cancer Preclinical Models(2012)178 cited
- → DNA Methylation Profiling Defines Clinically Relevant Biological Subsets of Non–Small Cell Lung Cancer(2012)86 cited
- → Activating Mutations in PIK3CB Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110β(2016)66 cited
- → A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer(2019)59 cited
- → Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples(2014)25 cited
- → Up-regulation of periostin and reactive stroma is associated with primary chemoresistance and predicts clinical outcomes in epithelial ovarian cancer.(2015)7 cited
- → Prognostic stromal and immune response expression patterns in early-stage colorectal cancer predicted by genes intrinsically expressed by tumor epithelial cells.(2019)2 cited
- → Circulating tumor cell (CTC) detection, N-terminal androgen (AR) characterization, and PTEN loss in metastatic or advanced castration resistant prostate cancer (CRPC).(2016)1 cited